Certified by Founder Lodge
Semarion
United Kingdom - Cambridge, Cambridgeshire
START UP
1 Disclosed Funding Rounds $3,800,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Unlock more data from adherent cell assays.
Our SemaCyte® platform turns adherent cells into barcoded, assay-ready, automation-friendly reagents, enabling researchers to multiplex cell mod
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 02 ,2026 | Unknown | $3,800,000 |
Parkwalk Advisors
The FSE Group
Found Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
